Transcode Therapeutics (RNAZ) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
Transcode Therapeutics (RNAZ) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 209.95 Bn | 195.96 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 180.35 Bn | 177.17 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.26 Bn | 124.41 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 82.62 Bn | 74.62 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 61.19 Bn | 56.00 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.61 Bn | 48.47 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.75 Bn | 30.44 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.58 Bn | 30.30 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.42 Bn | 29.42 Bn | 1.16 Mn | -0.40 |
| 10 | Transcode Therapeutics | 1.65 Mn | 1.65 Mn | - | -7.17 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.17 |
| Mar 31, 2026 | -21.28 |
| Dec 31, 2025 | -21.83 |
| Sep 30, 2025 | -5.82 |
| Jun 30, 2025 | -5.13 |
| Mar 31, 2025 | -2.51 |
| Dec 31, 2024 | -16.70 |
| Sep 30, 2024 | -8.55 |
| Jun 30, 2024 | -24.30 |
| Mar 31, 2024 | -21.35 |
| Dec 31, 2023 | -758.63 |
| Sep 30, 2023 | -55.69 |
| Jun 30, 2023 | -128.32 |
| Mar 31, 2023 | -224.43 |
| Dec 31, 2022 | -279.02 |
| Sep 30, 2022 | -251.49 |
| Jun 30, 2022 | -239.36 |
| Mar 31, 2022 | -176.85 |
| Dec 31, 2021 | -233.90 |
| Sep 30, 2021 | -135.15 |